Pfizer expects Covid vaccine demand for years


4/5/2021 21:50:00
Print
     .

Demand for Pfizer's Covid vaccine could bolster its revenues for years, the US drugs giant has said.

 

Pfizer said it was expecting "durable demand" for the vaccine, in a similar way to flu vaccines.

 

In the first three months of 2021, the vaccine generated revenues of $3.5bn (£2.5bn) as governments scrambled to try to contain the pandemic.

 

Revenue from the treatment is expected to hit $26bn this year - accounting for more than one third of Pfizer's sales.

 

The forecast is based on already-signed contracts for 1.6 billion vaccine doses to be delivered this year.

 

Pfizer said it expected to sign more deals this year, and was in supply talks with several countries for 2022 and beyond.

 

 

PUKmedia / BBC


 

Kurdish woman stabbed to death by her husband in France


A 36-year-old woman in France was stabbed to death and the country's police arrested her husband on charges of murder.

 

"On the morning of 31-3-2021, a man was arrested on cha...


»  UK activists commemorate Halabja tragedy
»  Kurdish politician competes to enter the German parliament

 

UNICEF calls on world governments to bring students back to schools


The United Nations International Children's Emergency Fund (UNICEF) launched a campaign to bring students back to school, warning that education suffers from a global crisis due to the covid pandem...


»  Will new US administration change its policy towards Syrian Kurds?
»  Consequences of Kurdistan’s oil dependent economy

Caricature